First Trust Advisors LP Legend Biotech Corp Transaction History
First Trust Advisors LP
- $108 Billion
- Q4 2024
A detailed history of First Trust Advisors LP transactions in Legend Biotech Corp stock. As of the latest transaction made, First Trust Advisors LP holds 20,669 shares of LEGN stock, worth $752,764. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,669
Previous 11,721
76.34%
Holding current value
$752,764
Previous $571,000
17.69%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding LEGN
# of Institutions
230Shares Held
82.6MCall Options Held
233KPut Options Held
339K-
Ra Capital Management, L.P. Boston, MA7.51MShares$273 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$248 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$218 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$208 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$208 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.1B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...